Home » Topics » Regulatory

Regulatory
RSS

Apotex launches generic ranitidine in U.S.

Sep. 16, 1997

Topical foscarnet for treatment of herpes labialis

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

RTP licenses improved propofol formulation to AMRAD

Sep. 5, 1997

Novartis migraine treatment nears U.S. approval

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

First approval for Zeneca's Seroquel

Sep. 3, 1997

Ranitidine shows no benefit in psoriasis

Sep. 2, 1997

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026